$1.05
0.0050.48%
Last update: Nov 13, 2:13 PM
INmune Bio Inc
INMBNASDAQ
INmune Bio (INMB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.17 | $-0.18 | 5.56 % |
| Q2 | Aug 6, 2026 | $-0.05 | $-0.20 | 75.0 % |
| Q1 | May 7, 2026 | $-0.20 | $-0.21 | 4.76 % |
| Q4 | Mar 30, 2026 | $-0.18 | $-0.27 | 33.3 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 9, 2024 | $14.00K | $30.00K | -53.3 % |
| Q4 | Mar 28, 2024 | $28.00K | $40.00K | -30.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.18 | $-0.20 | $-0.21 | $-0.27 |
| Actual | $-0.17 | $-0.05 | $-0.20 | $-0.18 |
| Surprise | +5.56% | +75.0% | +4.76% | +33.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.18 | $-0.18 |
| Revenue | ||
| Consensus | — | — |
